Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different initial loading doses of remimazolam besylate for hysteroscopic surgery
ChiCTR2100041690Phase 4Recruiting
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (4 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: Success rate of subjects with MOAA/S score <= 3 after the first trial drug administration. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100041690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041690.